Summary Keywords intermittent fasting, precision medicine, anti-obesity pharmacotherapy, cardiovascular disease, genetics, GLP-1, GIP Citation Eliopoulos AG, Gkouskou KK, Tsioufis K and Sanoudou D (2025) A perspective on intermittent fasting and cardiovascular risk in the era of obesity pharmacotherapy
Regular consultation ensures your treatment remains finely tuned to sustain meaningful, manageable weight loss
No, the gastric emptying delay is most pronounced during initial treatment and typically diminishes over weeks to months due to tachyphylaxis, whilst glucose-lowering and weight-reducing effects are maintained
10.1111/j.1600-0714.2012.01168.x 64 SuiJ.GuoJ.PanD.WangY.XuY.SunG.et al (2024)
Principles of Animal Nutrition
Orders typically arrive between 2 - 3 business days